Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Sees Significant Drop in Short Interest

Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) was the target of a large decline in short interest in October. As of October 31st, there was short interest totalling 800 shares, a decline of 98.0% from the October 15th total of 39,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Quantum Genomics Société Anonyme Price Performance

Shares of QNNTF stock remained flat at $0.10 during trading hours on Thursday. Quantum Genomics Société Anonyme has a 52 week low of $0.10 and a 52 week high of $0.10. The business’s 50-day moving average price is $0.10 and its 200 day moving average price is $0.10.

Quantum Genomics Société Anonyme Company Profile

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure.